FDA Guidance on EpCAM-Positive Cell Reduction by Filters

The FDA has released a guidance document related to the reduction of EpCAM-positive cells using filters. The document, identified by FDA-2025-N-5996-0030, is intended to provide clarity and information to regulated entities.

This guidance is primarily relevant to drug manufacturers and medical device makers involved in processes where EpCAM-positive cell reduction is a factor. Compliance officers should review the document to understand any implications for their product development, manufacturing, or quality control processes, although specific actionable steps or deadlines are not detailed in the provided information.